Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efanesoctocog Alfa Prophylaxis on Synovial Hypertrophy in Hemophilia A
NCT06941870Phase 4Recruiting
- Sponsor
- Sanofi
- Start
- Sep 2025
- Primary completion
- Oct 2027
- Countries
- 4
01
Overview
A Phase 4 trial of efanesoctocog alfa in hemophilia A, sponsored by Sanofi. Started Sep 2025; status: recruiting.
02
Drugs
efanesoctocog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT06941870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06941870.